PYPD Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs...

Stats
Today's Volume	5 248.00
Average Volume	3 337.00
Market Cap	7.11M
EPS	$0 ( 2024-02-14 )
Next earnings date	( $-1.960 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.250
ATR14	$0 (0.00%)

PolyPid Ltd. Correlation

10 Most Positive Correlations
APOP	0.902
RMRM	0.882
PAIC	0.848
GAINL	0.848
ISNS	0.844
SVOK	0.839
TDAC	0.835
SPRT	0.822
FORE	0.817
SNES	0.814

10 Most Negative Correlations
BOCH	-0.902
MMAC	-0.886
DSPG	-0.855
NETE	-0.855
AMRB	-0.837
SHSP	-0.808

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PolyPid Ltd. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.82M (0.00 %)
EPS:	$-16.99

Q4	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.84

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-3.40

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.130

Financial Reports:

No articles found.

PolyPid Ltd.

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.